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Neutrophils (polymorphonuclear leukocytes [PMNsl') migrate through endothe-
lium and subendothelial basement membrane when they leave the circulation and
enter the extravascular compartment. PMNs migrate by a process of regulated, re-
versible adherence to tissues, rather than by swimming (1, 2). The molecular mech-
anisms involved in PMN adherence endothelial cells (EC), the first cell that PMNs
encounter during migration from the blood to the extravascular space, are under
active investigation, and it is clear that molecules expressed by both the PMN and
the EC are important in regulating this adhesive interaction (3-8). Less is known
about the molecular mechanisms involved in PMN adhesion to connective tissue
proteins in the subendothelial basement membrane and interstitial space, the next
structures encountered by the migrating leukocyte.
A compelling body of experimental evidence has demonstrated that PMN recep-
tors, called the CD111CD18 glycoprotein complex, are involved when stimulated PMNs
adhere to biologic surfaces (3-6, 9-14). The CD11ICD18 glycoprotein complex con-
sists of three heterodimeric proteins, each with a separate a chain, and a common
(3 chain (15). The (3 chain is one of three /3 chains identified in a larger family of
related cell surface heterodimers called the integrins, which are all involved in cell-
cell and cell-protein interactions (16). The clinical course of patients congenitally
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lacking the CD11/CD18 integrins is marked by poor or absent accumulation ofPMNs
at sites of bacterial infections. Stimulated PMNs from such patients fail to adhere
to unactivated EC and to certain matrix proteins in vitro (3, 17-20). mAbs directed
against the common /3 chain ofthe CDII/CD18 completely inhibit adherence of stim-
ulated PMNs from normal donors to unactivated EC monolayersand to certain ma-
trix proteins in vitro (3, 4, 6), and systemic administration of anti-C,Dll/CD18 anti-
bodies to experimental animals inhibits tissue accumulation of PMNs in response
to chemoattractants (21, 22). These observations have demonstrated the importance
of CD1I/CD18-dependent PMN-adhesive interactions in the directed migration of
PMNs into sites of inflammation. However, PMNs can also adhere in vitro to cer-
tain surfaces, notably thrombin, LPS, or cytokine-stimulated EC monolayers, by
mechanisms that do not require CD11/CD18 integrins (4, 5, 23) . The contribution
of such CDII/CD18-independent PMN-adhesive interactions to PMN recruitment
into inflammatory sites is still being characterized.
In the experiments reported here, we have investigated the receptors involved in
stimulated PMN adherence to several extracellular matrix molecules in vitro. We
have found that the adherence of stimulated PMNs to the majority of protein-coated
surfaces tested can be totally inhibited by the anti-CD18 mAb, IB4. In contrast, stim-
ulated PMN adherence to laminin, the major glycoprotein ofmammalian basement
membrane, was only partially inhibited by mAb IB4. This CDll/CD18-independent
adherence appears to involve a distinct PMN adherence receptor for laminin . These
observations are important because interaction ofphagocytes with laminin and other
interstitial proteins may alter their functional state (24-26), in addition to influencing
directed migration.
Materials and Methods
Buffers and Reagents.
￿
Human serum albumin for infusion (HSA; Cutter Biologicals, Berke-
ley, CA), recombinant human C5a (C5a), FMLP, PMA (Sigma Chemical Co., St. Louis,
MO), platelet activating factor (PAF; Avanti Polar Lipids, Inc., Birmingham, AL), gelatin
(Type II from swine skin; Fisher Scientific Co., Pittsburgh, PA), and purified human plasma
fibronectin (Collaborative Research, Lexington, MA) were purchased. Recombinant human
TNFa was a gift from CetusCorp. (Emeryville, CA). Murine laminin andcollagen IV purified
from the EHS sarcoma, and DPGYIGSR peptide, were gifts of Dr. Hynda Kleinman (Na-
tional Institute of Dental Research, Bethesda, MD). Synthetic GRGDSP peptide was pur-
chased (Telios Pharmaceuticals, La Jolla, CA). HBSS and HBSS containing 1.2 mM Ca2'
and 0.8 mM Mg2' (HBSS2') were purchased from M.A. Bioproducts (Walkersville, MD).
Antibodies.
￿
Murine mAb IB4 (IgG2a), which binds to thea chain (CD18, 02 of the inte-
grin family) of the CDII/CD18 (27), was a gift from Dr. Samuel Wright (Rockefeller Univer-
sity, NY). Murine mAb B6H12 (IgGI), which recognizes the RGDS-binding leukocyte re-
sponse integrin (25) was a gift from Dr. Eric Brown (Washington University, St. Louis, MO).
Murine mAb W6/32 (IgG2a), which recognizes a common determinant on the HLA class
I molecule (28); rat mAb M1/70 (IgG2b), which recognizes the a2 chain of the CDll/CD18
(CDllb, Mac-1, or CR3; 15); and rat mAb R4-6A2 (IgGI), directed against murine IFN-'y
(29), were obtained from the American Type Culture Collection (Rockville, MD). AIIB2
and BIVF2 are rat mAbs raised against theJAR choriocarcinoma cell line (30). AIIB2 (IgGl)
and mAb 13 (rat IgG2a; 31) bind to the 0 subunit (0i) of the VLA integrins. BIVF2 is a
control mAb (IgG2a) that binds to the JAR cell but does not recognize an integrin. The
various mAbs used in these experiments are summarized in Table I.
IB4 was purified from ascites using protein A-Sepharose. W6/32 and B6H12 were purified
from ascites by octanoic acid precipitation (32). Ml/70, AIIB2, and BIVF2 were used as
tissue culture supernatants. R4-6A2 was partially purified by (NH4)2SO4 precipitation fromBOHNSACK ET AL.
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tissue culture supernatant, while mAb 13 was purified from tissue culture supernatant by
(NH4)2SO4 precipitation and ion exchange chromatography.
Subclass determination of AIIB2 and BIVF2 was performed with a commercially avail-
able kit (The Binding Site, San Diego, CA). The concentrations of mAbs in tissue culture
supernatant were determined by ELISA, using rat IgG (Calbiochem-Behring Corp., LaJolla,
CA) as a standard.
Rabbit polyclonal antiserum against the 67-kD laminin receptor was a gift from Dr. Tomeo
Sequi-Real (National Institute of Dental Research). Rabbit antibody against laminin, and
F(ab')2 fragments of the IgG fraction, were prepared as previously described (24).
EC Monolayers andSubendothelialMatrix.
￿
Confluent primary monolayers of human umbil-
ical vein EC were prepared as previously described in 24-mm tissue culture plastic wells (4,
33, 34). Subendothelial matrices were prepared by lysis of the overlying endothelial mono-
layers with 0.5% Triton X-100 for 30 min at 37°C, followed by treatment with 0.1 M
NH40H for 10 min at room temperature (34). The Subendothelial matrices were then
washed copiously with HBSS before use in the adherence assay.
PMNAdherenceAssay.
￿
The method for determining PMN adherence to protein-coated
plastic wells and to endothelial cell monolayers has been previously described in detail (4,
33, 34). PMNs were obtained from healthy adult donors, or from a patient with leukocyte
adhesion deficiency (CDII/CD18 deficiency). The clinical and laboratory characteristics of
the patient with CDII/CD18 deficiency will be the subject ofa more complete report (Shigeoka,
A. 0., andJ. F Bohnsack, manuscript in preparation). Briefly, this female patient's clinical
course has been characterized by recurrent cutaneous infections with no pus formation and
a peripheral bloodleukocytosis since her first several months of life. PMNs from this patient
completely lack detectable CD11/CD18 as determined by usingflow cytometry or by immu-
noprecipitation, using mAb IB4 to detect the /3 chain of the CDII/CD18 complex. PMNs
were isolated from heparinized blood by dextran sedimentation, hypotonic lysis, and Ficoll-
Hypaque density gradient centrifugation, as previously described (4, 33, 34). Purified PMNs
were suspended in HBSS2' containing 0.5% HSA (HBSS"/HSA) and labeled with
"'Indium oxine ('"In) by incubation with the "'In for 5 min at 37°C, followed by washing
to remove free "'In. '"In-labeled PMNs were suspended to 5.5 x 106/ml in HBSS2'/HSA.
For adherence to protein-coated substrates, 16-mm plastic tissue culture wells(Nunc, Roskilde,
Denmark) were coated with purified protein by incubation of 500 111 of protein diluted in
HBSS for at least 2 h at 37°C. The wells were then aspirated and washed once with HBSS
just before the adherence assay. Preliminary studies revealed that PMNs adhere readily to
uncoated tissue culture plastic wells, likely by a charge-induced mechanism. This high basal
adherence was inhibited in a concentration-dependent manner by precoating the wells with
a variety of proteins. Maximal inhibition of basal adherence occurred when wells were pre-
coated with proteins at 50 11g/ml. All proteins were therefore used at 50 lag/ml to coat the
wells, and basal adherence was found to be approximately equal to all protein-coated wells
used in this report (see Results). Adherence to endothelial cell monolayers and subendothe-
lial matrices was determined in 24-mm diameter wells prepared as described above.
PMNs were preincubated with mAb for 10 min at room temperature before addition to
the wells. mAbs were present throughout the course of the incubation. "In-PMNs (2251e1)
were added to 16-mm wells and 4501x,1 of "'In-PMNs to 24-mm wells, followed by addition
of 25 or 50111, respectively, ofthe different agonists. The PMNs were then allowed to adhere
for various lengths oftime at 37°C. At the end of the incubation interval, nonadherent cells
were removed by gentle aspiration and one wash with 0.5 ml HBSS. Nonadherent cells were
saved and counted. Counts associated with adherent cells were recovered by two cycles of
lysis with 1 M NH40H and vigorous scraping with a cotton tip applicator. The percentage
ofadherent cells was calculated as a percentage ofthe totalnumber ofcounts added to each well.
In experiments to determine the requirements for divalent cations for PMN adherence,
PMNs prepared in HBSS2'/HSA were pelleted by centrifugation and resuspended in
HBSS/HSA containing either EGTA, CaC12, or MgC12 at a final concentration of 1 mM.
In experiments to determine the receptor responsible for CD11/CD18-independent adher-
ence, II 'In-PMNs isolated from normals were incubated at 1.1 x 106/ml, with mAb IB4 at
50 11g/ml to maximally inhibit CDII/CD18-dependent adherence. PMA-stimulated adher-
ence to laminin in the presence of IB4 was compared in paired experiments to PMA-stimulated1224 NEUTROPHIL RECEPTOR FOR LAMININ
adherence to laminin in the presence of IB4 and various mAbs, and expressed as the percent
maximal adherence, calculated as follows: percent maximal adherence = 100 x [(PMA +
IB4) - (PMA + IB4 + mAb)]/[(PMA + IB4) - (BASAL)]; where (PMA + IB4), (PMA
+ IB4 + mAb), and (BASAL) represent the percent adherence undereach ofthese conditions.
Immunopnvipitation of?5ISurface-labeled PMNs.
￿
Purified human PMNs were washed four
times in PBS, pH 7.4. PMNs (1-2 x 108) were labeled with 2 mCi of Na'25I for 15 min using
250 Ag of chloroglycoluril (35; Sigma Chemical Co.), washed four times with PBS containing
2 mM KI, and solubilized in 0.01 M Tris, 0.145 M NaCl, pH 7.4, containing 0.5 mM EDTA,
25 wM nitroparaguanidinobenzoate, 2 leg/ml aprotonin, and 2 Rg/ml leupeptin (lysis buffer)
for 30 min at 37°C. After the solubilization, the lysates were centrifuged for 10 min in a
microfuge to remove insoluble material, and precleared successively with Sepharose 4BCL
and protein A-Sepharose. Aliquots of precleared cell lysates were mixed with AIIB2 (1 14g),
mAb 13 (5 IAg), or BIVF2 (1 jug) for 1 h at 4°C. Immune complexes were precipitated with
50 Ftl of goat anti-rat IgG agarose (Sigma Chemical Co.). After mixing for 2 h at 4°C, the
precipitates were washed exhaustively with lysisbuffer, and the pellets boiled in sample buffer
for SDS-PAGE. SDS-PAGE was performed according to the method of Laemmli (36) using
an 8% resolving gel and 4% stacking gel. Reduced samples were treated with 2% 2-ME.
Flow Cytometry.
￿
Purified PMNs (106 in 0.5 ml of HBSS/HSA) were incubated with mAbs
for 30 min on ice, washed twice, and then incubated with fluorescein-labeled goat anti-rat
antibody for an additional 30 min on ice. The cells were then washed, fixed with 2 % paraform-
aldehyde in 0.01 M P04, 0.145 M NaCl, pH 7.4, and analyzed on a Cytofluorograph II
(Ortho Diagnostic Systems Inc., Westwood, MA).
Statistical Analysis.
￿
Significance was determined using student's t-test for paired and un-
paired samples.
Results
Phorbol-stimulated PMNs Adhere to Matrix Proteins.
￿
We previously demonstrated that
stimulated human PMNsadhere in an enhanced fashion to complex subendothelial
matrices (14, 34). To examine the role of specific proteins in this interaction, we as-
sayed the adhesion of radiolabeled PMNs to matrices of laminin, collagen IV,
fibronectin, and gelatin, as well as to complex subendothelial matrices and EC mono-
layers (Fig. 1). There was very low adhesion of unstimulated PMNs to each surface
("basal adhesion"). This demonstrates that unstimulated PMNs from the peripheral
circulation do not avidly adhere to surfaces, and that exposure ofunstimulated PMNs
to these proteins or to unstimulated EC does not alone significantly increase PMN
adherence. When PMNs were stimulated with PMA, there was a dramatic (4-10-
fold) increase in adhesion; enhanced adhesion occurred when laminin, collagen IV,
TABLE I
mAbs Used in this Study
All target antigens are human unless otherwise specified .
mAb Species Subclass Antigen
I114 Mouse IgG2a /32 (C1318)
W6/32 Mouse IgG2a HLA class I
136H12 Mouse IgGI PMN LRI
AIIB2 Rat IgGI 01 of VLA
mAb 13 Rat IgG2a SI of VLA
BIVF2 Rat IgG2a JAR cells
R4-6A2 Rat IgGl Murine IFN--y
Ml/70 Rat IgG2b CD11bBOHNSACK ET AL .
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FIGURE 1 . Inhibition of ad-
herence of PMA-stimulated
PMNs to various substrates by
the anti-CD18 mAb, 1134 .
Tissue culture wells werecoated
with the various purified pro-
teins at 50 pg/ml . Monolayers
of human umbilical vein endo-
thelial cells (HUVEC) and
subendothelial matrix (SubEC
matrix) were prepared as de-
scribed in Materials and
Methods. PMA (10 ng/ml)
stimulated adherence to all sub-
strates to approximately the
same extent after a 30-min in-
cubation . mAb IB4 completely
inhibited adherence ofPMNs to
all substrates except SubEC ma-
trix and laminin. (") ;6 < 0.01
compared with basal adherence
to the same substrate. Percent adherence is the percentage ofPMNs adherent after a 30-min incubation
relative to the total number added per well . Data for each substrate are the means t SD. The number
of determinations for each substrate is indicated in parentheses .
or fibronectin was the substrate, as well as with complex subendothelial matrices .
This result suggests that oneormore ofthese proteins, which are majorcomponents
of the subendothelium (37), is a "target" for adhesive molecules on the surface of
stimulatedPMNs . Toexaminethe mechanism ofrecognition ofthe proteins by acti-
vated PMNs, we determined the effect of the anti-CD18 mAb, 1114, on stimulated
adherence ofPMNs to these surfaces, sincewe previously showed that PMNs stimu-
lated with chemotactic4actors adhere to a variety of proteins by a CD11/CD18-
dependent mechanism (4, 14) . IB4prevented enhanced PMA-stimulated PMN ad-
herence to fibronectin, gelatin, and collagen IV, as well as to EC (Fig . 1) . An isotype-
matched control mAb, W6/32, had no effect on stimulated PMN adherence (not
shown). This result supports previous observations that indicate that CD11/CD18
glycoproteins can interact with avariety ofsolubleand cell surface-associated ligands
(3, 4, 38-42) . In contrast, the percentage of PMA-stimulated PMNs adhering to
subendothelial matrices was reduced by only 35% by 1114 (Fig. 1) . Furthermore,
there was 1114-resistant adherence of PMA-stimulated PMNs to laminin (Fig. 1),
suggesting that laminin confers this property on the subendothelial matrix . There-
fore, we further characterized the mechanisms of stimulated PMN adherence to
laminin .
Laminin Is Recognised by StimulatedPMNs.
￿
A trivial explanation fortheIB4-resistant
binding was that laminin did not coat the plastic surface evenly, allowing PMNs
to bind to exposed plastic (see Materials and Methods) . Phase-contrast microscopy
demonstrated, however, that stimulated PMNs were uniformly distributed over the
laminin-coated wells, arguing against this possibility. Furthermore, F(ab')2 frag-
ments ofpolyclonal IgGantibody directed againstlaminin completely abolished the
1114-resistant adherence of PMA-stimulated PMNs to wells coated with laminin,
whereas F(ab')2 fragments ofpreimmune IgG did not affect the IB4-resistant ad-
herence(not shown). Inasecond strategy, we prepared composite matrices that con-1226
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tained both laminin and collagen IV . In these experiments, tissue culture wells were
first coated with collagen IV, washed, and then incubated with either laminin or
buffer. After an additional incubation, the wells were againwashed and the adher-
ence of PMA-stimulated PMNs was examined in the presence or absence ofIB4 .
Laminin binds specifically to collagen IV (43), and laminin bound to the collagen
IV-coated wells supported IB4-resistant adherence ofPMA-stimulatedPMNs (Fig .
2) . These data demonstrate that the IB4-resistant adherence ofthestimulated PMNs
resulted from an interaction of the PMNs with the laminin molecule itself.
StimulatedPMNs Adhere to Laminin by CDII/CD18-dependent and CI)11/CDIS-independent
Mechanisms. PMA-stimulatedPMNadherence to lamininwastime dependent, with
an onset within 5 min and maximal adherence at 30-60 min (Fig. 3) . IB4-resistant
adherence was present at 5 min and increased with time (Fig . 3) . Increasing the
concentration of IB4 from 10 to 50 wg/ml did not abolish PMA-stimulated PMN
adherence to laminin (from 56 t 8 to 46 t 15% with 10 and 50 I~g/ml of IB4,
respectively) . Preincubating thePMNs with IB4at 30 FAg/ml at 37°C with constant
agitation for 90 min also did not lead to a further reduction in PMA-stimulated
PMNadherence to lamininwhencompared with PMA-stimulated adherence ofPMNs
notpreincubated withIB4(Table II) . In the latter experiments, we followed thepro-
tocol that Nathan et al . (44) used to demonstrate that the massive respiratory burst
produced by TNFstimulated PMNs adherent to extracellular matrix proteins is
CD11/CD18 dependent . These data suggest that the IB4-resistant PMN adherence
to laminin did not merely reflect a higher affinity of'larninin for the CD11/CD18.
To examine this issue in a different way, we measured the stimulated adherence
ofPMNs from a patient with leukocyte adhesion deficiency. These PMNs, which
completely lack CDII/CD18 on their surface either in the basal state or after treat-
ment with PMA (as measured by analysis with flow cytometry using anti-CD11b
and anti-CD18 mAb), were less adherent to lamininthan were control PMNs (Table
III) . This observation further demonstrates that the CD11/CD18contributes toPMN
FIGURE 2.
￿
Lamininbound to
collagen IV supports IB4-
resistant adherence . Tissue cul-
ture wells were coated with col-
lagen IV (50 pg/ml), then
washed, and either laminin or
buffer was added. After an ad-
ditional incubation, the plates
were washed and adherence
tested in the presence orabsence
ofPMA (10 ng/ml) and mAb
IB4 (10 Wg/ml). Data are the
means t SD from fourseparate
experiments . (')p< 0.01, com-
pared with basal adherence to
the same substrate.BOHNSACK ET AL.
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￿
Theexpression of IB4-resistant adherence to lamininis time dependent. PMNs were
tested for adherenceto (A) laminin or (B) gelatin at different times afteraddition of PMA (10
ng/ml), in the presence or absence of IB4 at 10 pg/ml. IB4-resistant adherence was detectable
as early as 5 min after addition of PMA in laminin-coated wells and persisted for at least 60
min. PMA-stimulated adherence to gelatin at each time point was always completely inhibited
by IB4. Data aremeans t SD. The number of separate experiments foreach time point is indi-
cated in parentheses.
adherence to laminin. However, there was a three to fourfold increase in adhesion
of PMA-stimulated PMNs from theCDll/CD18-deficient patient to laminin, whereas
there was no increased adhesion to gelatin or EC (Table III). These data demon-
strate that PMA-stimulated PMNs adhere to laminin by a mechanism that does
not require expression or upregulation of the CD11/CD18.
TheExpression of CD111CD18-independentPMNAdhesion to Laminin Is AgonistSpecoc
andDependent on the Presence ofDivalent Cations. Several other agonists were exam-
ined for their ability to stimulate CDll/CD18-independent adherence to laminin.
As shown in Fig. 4, FMLP, PAF, and recombinant human C5aall stimulated PMN
adherence to laminin. This adherence was completely CD1I/CD18 dependentwhen
assayed aftera30-min incubation. In contrast, calcium ionophoreA23187 andTNFtx
TABLE II
Preincubation of PMNs with IB4 Does not Abolish
PMNAdherence to Laminin
PMNs were preincubated aloneor with IB4at 30pg/mlfor 0 or90 minat 37°C
with constant agitation, before determining adherenceto laminin in theabsence
(basal) or presence of PMA at 10 ng/ml. Data are the means and SDs of one
experiment performed in triplicate.
Agonist
No
preincubation
90-min
preincubation
Basal 9 t 2 6 t 1
PMA (10 ng/ml) 88 t 1 77 t 1
PMA + IB4 64 1 1 56 ± 31228
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TABLE III
Stimulated PMNs from a CD111CD18-deficient Patient
Adhere to Laminin
Adherence ofPMNs from a patient with CD11/CD18 deficiency or from a nor-
mal control subject to laminin, gelatin, or EC monolayers was compared . PMNs
were either allowed to adhere in the absence of any stimulus (basal) for 30 min
or in the presence of PMA (laminin and gelatin), or phorbol dibutyrate (EC
monolayers) at 10 ng/ml . Data are the means and SDs from one experiment .
The numbers in parentheses are the numbers of replicates in this experiment .
Data for adherence to laminin and gelatin are representative of three separate
experiments . Adherence to EC monolayers was performed once .
both stimulated PMN adherence to laminin in a CDll/CD18-independent manner,
but not to the same extent as didPMA(Fig. 4) . Thus, an agonist important in inflam-
matory tissue injury, TNF-ci (45), as well as pharmacologicagonists(PMA, calcium
ionophore), induced CD11/CD18-independentPMN adhesion to laminin, whereas
all the chemotactic factors induced adhesion that was completely mediated by the
CD11/CD18.
Resuspending the PMNs in buffer without added divalent cations completely in-
hibited PMA-stimulated adherence to gelatin but not to laminin (Fig . 5) . This ad-
herence to laminin was completely CD11/CD18 dependent (inhibited by 04), and
was probably supported by the small amount of divalent cation remaining in the
buffer since chelation of divalent cations with EGTA completely abolished the ad-
FIGURE 4 . The expression of IB4-
resistant PMN adherence to laminin
is agonistdependent . The ability ofIB4
(10 lAg/ml) to inhibit adherence of
PMNs stimulated withvarious agonists
was tested on laminin substrates. IB4
completely inhibited adherence of
PMNs to laminin stimulated with
FMLP at 10-6 M, PAF at 10-6 M, or
recombinant human C5a at 100 ng/ml,
but did not completely inhibit adher-
ence stimulated by recombinantTNRa
at 10-9 M, or calcium ionophore
A23187 at 500 ng/ml . IB4 completely
inhibited PMN adherence to gelatin
for every agonist tested. The number
ofexperiments performed for each sep-
arate experiment is indicated in paren-
theses. (') p < 0.01 compared with
basal adherence to laminin .
Subject Laminin
Percent adherence
Gelatin EC monolayers
Patient
Basal 9 t 4 (3) 8 ± 1 (3) 7 .8 (1)
Stimulated 28 ± 2 (3) 6 1 1 (3) 3 .0 (1)
Normal
Basal 21 t 3 (3) 12 t 0 (3) 9.4(l)
Stimulated 94 t 1 (3) 92 t 0 (3) 74 .1 (1)BOHNSACK ET AL .
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FIGURE 5 . CDII/CD18-inde-
pendent adherence to laminin
is divalent cation dependent .
I I IIn PMNs were pelleted and
resuspended in HBSS/HSA
(HBSSwithout added divalent
cations) or in HBSS/HSA con-
taining 1 mM EGTA, 1 mM
Ca2+, or 1 mM Mg2+ . Adher-
ence ofPMNs to laminin or to
gelatin wasdetermined after 30
min in the presence or absence
of PMA at 10 na/ml .
herence of PMA-stimulated PMNs to laminin (Fig . 5) . The addition of 1 mM
Mgt+ , but not 1 mM Ca2+ , restored PMN adherence to gelatin . This concentra-
tion of Mgt' also supported CDII/CD18-dependent adherence of PMNs to lam-
inin, whereas CDII/CD18-independent adherence did not occur in the presence of
1 mM Ca2" alone (Fig . 5) . These data demonstrate that CDII/CD18-independent
adherence to laminin is Mgt' dependent .
CD111CD18-independent PMNAdherence to Laminin Is Inhibited byAnti-VLA mAbs .
￿
We
next attempted to determine what alternative adherence receptor mediates
CD11/CD18-independentPMN adherence to laminin . We found that neither poly-
clonal antibody directed against the 67-kD laminin receptor present inPMN gran-
ules (46), norDPGYIGSR peptide, a sequence in laminin that binds to the 67-kD
receptor (47), inhibited CDII/CD18-independent adherence (not shown) . We then
considered members of the 0-1 integrin family, since at least three of these,VLA-2,
VLA-3, and VLA-6, have been shown to mediate cell adhesion to laminin (48-50) .
mAb AIIB2 andmAb 13, which bind to the common /3 t subunit of theVLA family
of integrins, significantly inhibited adherence of normal PMNs to laminin when
themAb IB4 was used to block CDII/CD18-dependent adherence (Fig . 6) . In exper-
iments similarto those shown in Fig. 6, mAb 13 inhibited CD11/CD18-independent1230
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FIGURE 6 .
￿
Anti-0I mAbs sig-
nificantly inhibit CDII/CD18-in-
dependent adherence to lam-
inin . Adherence of PMNs to
laminin after 30min in the pres-
ence of PMA at 10 ng/ml and
IB4 at 50,ug/ml was compared
with adherence of PMA-
stimulatedPMNs to laminin in
the presence of IB4 and various
mAbs, rat IgG, or peptide
GRGDSP Final concentrations
of AIIB2 and BIVF2 were 2
Fig/ml, while mAb 13, W6/32, B6H12, and rat IgG were at 50 gg/ml . GRGDSP was used at a final
concentration of 300 hg/ml . Numbers in parentheses indicate the number ofseparate experiments . (')
p < 0.01 compared with paired experiments with PMA + IB4 only.
adherence at concentrations as low as 2 Ag/ml, but inhibition was most consistent
at concentrations >,10 /,tg/ml . In the absence of IB4, neither AIIB2 nor mAb 13 in-
hibited PMA-stimulated adherence of PMNs from normal donors to laminin (not
shown) . Polyclonal ratIgG, synthetic peptide GRGDSP, and mAbsBIVF2, W6/32,
and B6H12 did not inhibit CD11/CD18-independent adherence (Fig. 6) .
The effect of the anti-Rt mAbs was most clearly observed when adherence of
PMNs from the CDII/CD18-deficient patient was examined . PMA-stimulated ad-
herence of PMNs to laminin in this non-CD11/CD18-mediated system was com-
pletely blocked by mAb AIIB2 (Table IV) and by mAb 13 (Fig . 7) . Inhibition by
mAb 13 was concentration dependent, with complete inhibition occurring at con-
centrations of mAb 13 >,10 hg/ml (Fig . 7) . The control mAbs BIVF2 and W6/32
did not inhibit adherence of CDII/CD18-deficient PMNs to laminin (Table IV and
Fig . 7) .
mAb AIIB2 Recognizes a Receptor on the Surface ofPMNs.
￿
We determined whether
AIIB2 and mAb 13 recognize an antigen on PMNs, since it has previously been
reported that PMNsdo not possessVLA receptors on their surface (51) . Both mAb
AIIB2 andmAb 13 immunoprecipitated a protein from t25I surface-labeledPMNs.
Underboth reducing and nonreducing conditions, the immunoprecipitatemigrated
on SDS-PAGE as a broad band with anM r of -125,000-135,000 daltons (Fig. 8).
TABLE IV
AIIB2 Inhibits Stimulated Adherence of CD11/CD18-deficient
PMNs to Laminin
Adherence of PMNs from a CD11/CD18-deficient patient to laminin in the
presence or absence ofPMA at 10 ng/ml was determined after a 30-min incuba-
tion as described in Materials and Methods . PMNs were preincubated with tis-
sue culture supernatant containing mAb AIIB2 or BIVF2 for 10 min before and
throughout the course ofthe adherence assay at a final concentration of2 Fig/ml .
Data are the means t SDs from one experiment performed in quadruplicate,
representative of two experiments .
Percent adherence
Agonist No mAb AIIB2 BIVF2
Basal 6 f 2 ND ND
PMA 25 f 1 5 t 1 23 ± 4mAb, up/ml
BOHNSACK ET AL .
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FIGURE 7 .
￿
Anti-01 mAb 13 inhibits adher-
ence ofPMA-stimulated CD11/CD18-deficient
PMNs to laminin . mAb 13 or W6/32was in-
cubated with PMNs from a CDII/CD18-
deficient patient at the indicated concentra-
tions, and adherence ofthePMNs to laminin
wasdetermined after 30 min in the presence
of PMA at 10 ng/ml .
This band was clearly distinguishablefrom theVLA antigens (VLA-2, VLA-5, and
VLA-6; 52) present on platelets, which appeared as two bands at 135,000-140,000
and 115,000-120,000 daltons (Fig . 8) . In addition, experiments with flow cytometry
indicate that both mAbs 13 and AIIB2 specifically bind to PMNs (Fig. 9) . These
data demonstrate that the anti-a1 mAbs both identify a surface protein on PMNs
and block PMN adhesion to laminin, indicating that humanPMNs possess a sur-
face receptor, distinct from the CDII/CD18, that mediates adherence to this base-
ment membrane protein. This distinct PMN adherence receptor appears to be a
member of the 01 family of integrins .
Discussion
These experiments demonstrate that adherence of stimulated human PMNs to
laminin involves the CD11/CD18 glycoprotein complex, since the anti-CD18 mAb,
IB4, decreased agonist-stimulated PMN adherence to laminin . However, laminin
possesses aunique property as an adherence substrate for stimulated PMNs, since
FIGURE 8 .
￿
Autoradiography of8%
SDS-PAGE analysis of immuno-
precipitated 1251 surface-labeled
PMNs and platelets . (Lanes 1-3)
PMNs ; (lanes 4-6) platelets . (Lanes
1 and 4) AIIB2; (lanes 2 and 5)
mAb 13 ; (lanes 3and 6) BIVF2 . R,
samples reduced with 2% 2-ME ;
NR, nonreduced samples . PMNs
were not stimulated before being la-
beled and solubilized with de-
tergent .1232
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FIGURE 9.
￿
Flow cytometryof PMNs from normal donors stained with anti-/31 mAb 13 (3 kg)
or A1IB2 (1 pg), anti-CD116 mAb Ml/70(12 pg), or the control mAbs BIVF2(3 wg; left) or R4-
6A2 (I hg; right). See Materials and Methods for details of experimental procedures. Fluores-
cence intensity is expressed on a three-decade log scale.
adherence of PMA-stimulated PMNs to laminin, and laminin-containing suben-
dothelialmatrix, was only partially inhibited by mAb IB4, whereasPMA-stimulated
PMN adherence to all other surfaces tested was completely inhibited by IB4.
There were at least two possible explanations for the difference between PMA-
stimulated PMN adherenceto laminin and adherenceto the other substrates exam-
ined. One possibility was that CDII/CD18 mediatesboth the 1134-sensitive and IB4-
resistant adherence to laminin, but that the affinity of CDII/CD18 for laminin was
greater than for the other ligands, such as gelatin or fibronectin. This explanation
seems unlikely since evenveryhigh concentrations ofIB4 andprolonged preincuba-
tion ofPMNs with IB4 at 37°C failed to inhibit the PMA-stimulated PMN adher-
ence tolaminin. In addition, PMA induced PMNs from aCDIl/CD18-deficient pa-
tient to adhere to laminin-coated substrates, but not to gelatin or endothelial cell
monolayers, documenting that adhesion to laminin occurs in the absence ofleuko-
cyte 02 integrins.
The alternative explanation, therefore, is that there is a separate PMN receptor
for laminin. Amember oftheVLA integrin receptor family would be agoodcandi-
date to be such a PMN laminin receptor since several members ofthe VLA family,
VLA-2, VLA-3, and VLA-6, have been reported to mediate adherence of connec-
tive tissue cells and platelets to laminin substrates (48-50). Furthermore, integrins
require divalent cations for ligand binding (16), and CD11/CD18-independent ad-
herence to laminin requires the presence of the divalent cation Mgt' for expres-
sion(Fig. 5). Indeed, we foundthat mAbs 13 andAIIB2, whichrecognizethecommon
al subunit of the VLA integrins, significantly inhibited the CD11/CD18-indepen-
dent adherence of PMA-stimulated PMNs to laminin.
It has previously been reported that VLA receptors are not present on mature
PMNs, since flow cytometry experiments did not detect binding ofthe anti-al mAb
AIA5 toPMNs(51). Bycontrast, ourflowcytometryexperiments indicatethatmAbs
13 and AIIB2 do bind to PMNs, although the observed fluorescence intensity indi-
cates that the antigen recognized by mAbs 13 and AIIB2 is present on the surface
of unstimulated PMNs at low density. It is interesting to note that both mAbs 13
and AIIB2 differ from AIA5 in that both mAb AIIB2 and mAb 13 block adherenceBOHNSACK ET AL.
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ofcellsto several extracellularmatrix molecules(31, 53), suggesting that thesemAbs
have adifferent affinity for the VLAa chain, orthat they bind to a separate epitope
on the 01 chain than mAb AIA5. We also found that these anti-(31 mAbs immuno-
precipitate a protein from surface-labeled PMNs. Interestingly, this precipitate does
not contain a band that migrates like the ,(31 chain immunoprecipitated from
surface-labeledplatelets. There are several possible explanations for thediscrepancy.
One is that the mAbs crossreact with a nonVLA molecule on PMN cell surface
membranes. Ifso, ourfunctionaldata indicate that thismoleculemediatescell binding
to laminin, identifyingitas a novel receptor formatrix proteins. Another possibility
is that the /3 chain is poorly labeled on PMNs by the method we have used, and
only the a chain is recognizable on the autoradiograms. Finally, the VLA 0 chain
from PMNs may have a different M, from that in platelets, due, for example, to
differences in glycosylation. Ifso, the broad band seen in Fig. 8 may be the (3 chain,
ora closely spaced dimer ofa and(3 chains. These possibilities are currently under
investigation.
These observations clearlydemonstrate that PMNs have atleast twoseparate mech-
anisms by which they adhere tolaminin, one that isCDII/CD18 dependent andone
that is mediated by an independent laminin receptor that has similarity to a VLA
/31 integrin. These findings confirm that PMNs can adhere by CD11/CD18-indepen-
dent mechanisms (4, 5, 23). It is not clear what contribution such CDII/CD18-
independent adherence makes to PMN recruitment into sitesofinflammation. The
inability ofPMNs from CD11/CD18-deficient patients to accumulate at sites ofin-
fection suggests that the CD11/CD18 is a dominant and critical receptor involved
in PMN adherence and migration in vivo. However, PMNs may utilize regulated
expression ofdifferent surface receptorsto allow controlled adhesion todifferentstruc-
tures(endothelial cells, connective tissue proteins, epithelial cells oftheairway, peri-
toneum, etc.) that are encountered as they migrate to extravascular sites. The sur-
face molecule that we describe may be such a receptor. In addition, distinct PMN
receptors for extracellular matrix proteins, such as the PMN receptor for laminin
described here or the recently described PMN RGDS integrin (25), may allow the
PMN to discriminately recognize its extravascular environment, and alterits func-
tional state accordingly (24-26).
Summary
We used mAbs against polymorphonuclear leukocyte (PMN) surface proteins to
investigate the mechanisms by which stimulated human neutrophils (PMNs) ad-
here in vitrotolaminin, the major glycoprotein ofmammalian basement membrane.
mAb IB4, which is directed against the common (32 chain of the CD11/CD18, only
partially inhibited the adherence ofPMA-stimulated PMNs to both laminin and
to subendothelial matrices. In contrast, IB4 completely inhibited PMA-stimulated
PMN adherence togelatin, fibronectin, collagen IV, and endothelialcell monolayers.
PMA-stimulated PMNs from apatientwithsevere congenital CD11/CD18deficiency
also adhered to laminin, but not to gelatin or endothelial cell monolayers. There-
fore, PMA-stimulated PMNs adhere tolaminin by both CDII/CD18-dependent and
CDII/CD18-independent mechanisms. Expression ofCD11/CD18-independent ad-
herence tolaminin was agonist dependent, occurring after stimulation with the cal-1234
￿
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cium ionophore A23187 and recombinant TNRa, but not with the chemotactic fac-
tors FMLP, platelet activating factor, or recombinant human C5a. Expression of
CD11/CD18-independent adherence was also divalent cation dependent, occurring
in the presence of Mgt' but not Cat+ as the sole added divalent cation. The mAbs
AIIB2 and 13, which are directed against the 01 subunit of the VLA integrins,
significantly inhibited the CD11/CD18-independent adherence of normal PMNs to
laminin, and completely abolished the adherence of CD11/CD18-deficient PMNs
to laminin. Both anti-(31 mAbs bound to PMNs, as demonstrated by flow cytom-
etry, and immunoprecipitated a membrane molecule of M, 130,000 daltons from
1251-labeled, detergent-solubilized PMNs. These data suggest that human PMNs
possess (31 and 02 classes of integrins, and that both mediate PMN adherence.
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